VANI
Vivani Medical Inc.
NASDAQ: VANI · HEALTHCARE · BIOTECHNOLOGY
$1.34
+1.52% today
Updated 2026-04-30
Market cap
$115.97M
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-0.43
Dividend yield
—
52W range
$1 – $2
Volume
0.3M
Vivani Medical Inc. (VANI) Financial statements
SEC filings — annual and quarterly data.
Income statement — annual
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $1.37M | $1.56M | $3.40M | $8.95M | $3.98M | $7.96M | $6.90M | $3.38M | $1000.00 | $260.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Revenue growth (YoY) | — | +14.5% | +117.1% | +163.4% | -55.5% | +99.8% | -13.4% | -51.0% | -100.0% | -74.0% | -100.0% | — | — | — |
| Cost of revenue | $4.40M | $5.63M | $3.56M | $4.30M | $9.35M | $7.75M | $4.89M | $2.15M | $167000.00 | $345000.00 | $381000.00 | $357000.00 | $400000.00 | $424000.00 |
| Gross profit | $-3.03M | $-4.06M | $-160283.00 | $4.65M | $-5.36M | $211000.00 | $2.01M | $1.23M | $-167000.00 | $-345000.00 | $-381000.00 | $-357000.00 | $-400000.00 | $-424000.00 |
| Gross margin | -221.6% | -259.7% | -4.7% | 51.9% | -134.6% | 2.6% | 29.1% | 36.3% | -16700.0% | -132692.3% | — | — | — | — |
| R&D | $3.05M | $3.25M | $5.04M | $3.04M | $5.35M | $7.99M | $10.21M | $16.50M | $6.87M | $11.00M | $14.17M | $16.97M | $15.74M | $18.13M |
| SG&A | $4.03M | $4.17M | $6.57M | $8.22M | $10.08M | $10.93M | $10.69M | $9.23M | $2.38M | $2.32M | $5.37M | $10.00M | $8.93M | $9.43M |
| Operating income | $-16.02M | $-18.00M | $-21.23M | $-20.05M | $-33.21M | $-28.71M | $-34.83M | $-30.60M | $-9.24M | $-13.32M | $-21.24M | $-26.96M | $-24.68M | $-27.56M |
| Operating margin | -1171.8% | -1150.1% | -624.9% | -224.0% | -833.4% | -360.5% | -505.0% | -905.5% | -924300.0% | -5124230.8% | — | — | — | — |
| EBITDA | $-15.69M | $-17.64M | $-27.89M | $-19.68M | $-32.75M | $-28.06M | $-34.66M | $-33.18M | $-8.89M | $-12.98M | $-19.16M | $-25.30M | $-24.28M | $-27.13M |
| EBITDA margin | -1147.4% | -1127.2% | -820.8% | -219.9% | -821.8% | -352.3% | -502.6% | -981.9% | -888900.0% | -4991538.5% | — | — | — | — |
| EBIT | $-16.01M | $-17.96M | $-28.17M | $-20.02M | $-33.18M | $-28.52M | $-35.09M | $-33.59M | $-9.24M | $-13.32M | $-19.54M | $-25.65M | $-24.68M | $-27.56M |
| Interest expense | $267031.00 | $5.01M | $7.03M | $29000.00 | — | — | $0.00 | $0.00 | $0.00 | $550000.00 | $7.35M | — | — | — |
| Income tax | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Effective tax rate | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | $-16.28M | $-22.97M | $-35.20M | $-20.02M | $-33.18M | $-28.52M | $-35.09M | $-33.59M | $-9.28M | $-12.77M | $-13.89M | $-25.65M | $-23.49M | $-26.61M |
| Net income growth (YoY) | — | -41.1% | -53.3% | +43.1% | -65.7% | +14.1% | -23.1% | +4.3% | +72.4% | -37.7% | -8.7% | -84.7% | +8.4% | -13.3% |
| Profit margin | -1190.7% | -1467.7% | -1036.0% | -223.7% | -832.6% | -358.1% | -508.9% | -994.1% | -927900.0% | -4912692.3% | — | — | — | — |